Other languages Huadong Medicine Co., Ltd

Equities

000963

CNE0000011S1

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 26/04/2024 am IST			5-day change	1st Jan Change
32.77 ^CNY	+0.06%		+4.03%	-20.96%

25/04	Huadong Medicine Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
18/04	Huadong Medicine's 2023 Profit Jumps 14%	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Huadong Medicine Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
Huadong Medicine's 2023 Profit Jumps 14%	18/04
Huadong Medicine Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	17/04
El primer medicamento chino bioequivalente a Ozempic solicita su aprobación	03/04
China's first biosimilar Ozempic drug applies for approval	03/04
Huadong Medicine to Build 2 Billion Yuan Biopharma Innovation Center	09/02
Huadong Medicine to Invest 2 Billion Yuan in Biopharma Innovation Center	09/02
Huadong Medicine's 2023 Profit to Climb Up to 14.5%	01/02
Huadong Medicine Eyes Exclusive Marketing Rights for Cancer Drug Senaparib in China for 290 Million Yuan	21/12
Huadong Medicine's Unit Gains Chinese Drug Regulator's Nod to Trial Sirolimus Oral Solution	06/12
Huadong Medicine's Unit, Partners to Invest in Pharmaceutical Firm	14/11
Huadong Medicine Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	24/23/24
Huadong Medicine's Unit Gets Nod to Test Weight Management Drug; Shares Up 3%	15/23/15
Huadong Medicine Enters Exclusive Licensing Agreement with Denmark’s MC2	01/23/01
Huadong Medicine’s H1 Profit Rises 7%; EPS, Revenue Miss Forecasts	16/23/16
Huadong Medicine Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	15/23/15
Huadong Medicine Buys Rights to US Skincare Drug For $100 Million	14/23/14
Arcutis Authorizes Huadong Medicine Unit to Manufacture, Commercialize Topical Roflumilast in China, Southeast Asia	10/23/10
Huadong Medicine Registers Obesity Drug	05/23/05
Huadong Medicine Unit Gets Nod to Conduct Trial on Tumor Drug	30/23/30

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Huadong Medicine Co., Ltd

Equities

000963

CNE0000011S1

Other languages

Filters